Connect with us

Digital Health

Seattle startup Olamedi building platform to automate health clinic communications

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…

Published

on

This article was originally published by GeekWire
Olamedi co-founders Daniel Sarfati, left, and Noah Loudon. (Photo courtesy of Olamedi)

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software platform.

Olamedi is a year-old company co-founded by CEO Daniel Sarfati and COO Noah Loudon.

Sarfati spent two years at Amazon and two at home-selling platform Knock as a software developer. He was most recently the co-founder and CTO at Mexico City-based health tech platform HelloDoctor.

Loudon is a University of Washington graduate who previously spent 10 years at swag maker Kotis Design. He was most recently VP of sales at HelloDoctor.

Olamedi helps automate patient communication and track long-term outcomes from a single platform. The software enables clinics to use a unified interface without making changes to existing software or record management systems, and it replaces front-desk conversations with smart questionnaires and modular workflows.

The startup just raised $80,000 via a SAFE financing round led by angel investors including Jamie McAvity, CEO of Cormint Data Systems and a prior investor in Knock. Sarfati and Loudon have put $400,000 of their own capital into the company.

The founders say they are currently working with partners to develop and test their platform and intend to launch in Q4 of 2024.


Digital Health

Keep it Short

By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading
Markets

ETF Talk: AI is ‘Big Generator’

Second nature comes alive Even if you close your eyes We exist through this strange device — Yes, “Big Generator” Artificial intelligence (AI) has…

Continue Reading

Trending

Seattle startup Olamedi building platform to automate health clinic communications

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…

Published

on

This article was originally published by GeekWire
Olamedi co-founders Daniel Sarfati, left, and Noah Loudon. (Photo courtesy of Olamedi)

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software platform.

Olamedi is a year-old company co-founded by CEO Daniel Sarfati and COO Noah Loudon.

Sarfati spent two years at Amazon and two at home-selling platform Knock as a software developer. He was most recently the co-founder and CTO at Mexico City-based health tech platform HelloDoctor.

Loudon is a University of Washington graduate who previously spent 10 years at swag maker Kotis Design. He was most recently VP of sales at HelloDoctor.

Olamedi helps automate patient communication and track long-term outcomes from a single platform. The software enables clinics to use a unified interface without making changes to existing software or record management systems, and it replaces front-desk conversations with smart questionnaires and modular workflows.

The startup just raised $80,000 via a SAFE financing round led by angel investors including Jamie McAvity, CEO of Cormint Data Systems and a prior investor in Knock. Sarfati and Loudon have put $400,000 of their own capital into the company.

The founders say they are currently working with partners to develop and test their platform and intend to launch in Q4 of 2024.


Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Seducing stocks: Canoo Inc (NASDAQ:GOEV 5.43%), Ginkgo Bioworks Holdings Inc (NYSE:DNA -1.12%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading

Trending